Cargando…
Inflammation as a central mechanism in Alzheimer's disease
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles. Over the last decade, the presence of a sustained immune response in the brain has emerged as...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214864/ https://www.ncbi.nlm.nih.gov/pubmed/30406177 http://dx.doi.org/10.1016/j.trci.2018.06.014 |
_version_ | 1783368023324753920 |
---|---|
author | Kinney, Jefferson W. Bemiller, Shane M. Murtishaw, Andrew S. Leisgang, Amanda M. Salazar, Arnold M. Lamb, Bruce T. |
author_facet | Kinney, Jefferson W. Bemiller, Shane M. Murtishaw, Andrew S. Leisgang, Amanda M. Salazar, Arnold M. Lamb, Bruce T. |
author_sort | Kinney, Jefferson W. |
collection | PubMed |
description | Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles. Over the last decade, the presence of a sustained immune response in the brain has emerged as a third core pathology in AD. The sustained activation of the brain's resident macrophages (microglia) and other immune cells has been demonstrated to exacerbate both amyloid and tau pathology and may serve as a link in the pathogenesis of the disorder. In the following review, we provide an overview of inflammation in AD and a detailed coverage of a number of microglia-related signaling mechanisms that have been implicated in AD. Additional information on microglia signaling and a number of cytokines in AD are also reviewed. We also review the potential connection of risk factors for AD and how they may be related to inflammatory mechanisms. |
format | Online Article Text |
id | pubmed-6214864 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-62148642018-11-07 Inflammation as a central mechanism in Alzheimer's disease Kinney, Jefferson W. Bemiller, Shane M. Murtishaw, Andrew S. Leisgang, Amanda M. Salazar, Arnold M. Lamb, Bruce T. Alzheimers Dement (N Y) Special Issue from the Centers of Biomedical Research Excellence (COBRE) and Center for Neurodegeneration and Translational Neuroscience (CNTN) Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is characterized by cognitive decline and the presence of two core pathologies, amyloid β plaques and neurofibrillary tangles. Over the last decade, the presence of a sustained immune response in the brain has emerged as a third core pathology in AD. The sustained activation of the brain's resident macrophages (microglia) and other immune cells has been demonstrated to exacerbate both amyloid and tau pathology and may serve as a link in the pathogenesis of the disorder. In the following review, we provide an overview of inflammation in AD and a detailed coverage of a number of microglia-related signaling mechanisms that have been implicated in AD. Additional information on microglia signaling and a number of cytokines in AD are also reviewed. We also review the potential connection of risk factors for AD and how they may be related to inflammatory mechanisms. Elsevier 2018-09-06 /pmc/articles/PMC6214864/ /pubmed/30406177 http://dx.doi.org/10.1016/j.trci.2018.06.014 Text en ©?2018 Published by Elsevier Inc. on behalf of the Alzheimer's Association. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Special Issue from the Centers of Biomedical Research Excellence (COBRE) and Center for Neurodegeneration and Translational Neuroscience (CNTN) Kinney, Jefferson W. Bemiller, Shane M. Murtishaw, Andrew S. Leisgang, Amanda M. Salazar, Arnold M. Lamb, Bruce T. Inflammation as a central mechanism in Alzheimer's disease |
title | Inflammation as a central mechanism in Alzheimer's disease |
title_full | Inflammation as a central mechanism in Alzheimer's disease |
title_fullStr | Inflammation as a central mechanism in Alzheimer's disease |
title_full_unstemmed | Inflammation as a central mechanism in Alzheimer's disease |
title_short | Inflammation as a central mechanism in Alzheimer's disease |
title_sort | inflammation as a central mechanism in alzheimer's disease |
topic | Special Issue from the Centers of Biomedical Research Excellence (COBRE) and Center for Neurodegeneration and Translational Neuroscience (CNTN) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214864/ https://www.ncbi.nlm.nih.gov/pubmed/30406177 http://dx.doi.org/10.1016/j.trci.2018.06.014 |
work_keys_str_mv | AT kinneyjeffersonw inflammationasacentralmechanisminalzheimersdisease AT bemillershanem inflammationasacentralmechanisminalzheimersdisease AT murtishawandrews inflammationasacentralmechanisminalzheimersdisease AT leisgangamandam inflammationasacentralmechanisminalzheimersdisease AT salazararnoldm inflammationasacentralmechanisminalzheimersdisease AT lambbrucet inflammationasacentralmechanisminalzheimersdisease |